Unichem Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2024, titled "Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg.".